Gamma Biosciences invests in Nirrin, looks to address ‘large unmet need’ for accurate real-time in-line analytics 27-Sep-2021 By Jane Byrne The biopharma industry continues to seek technologies that enable process control, while improving process development times and quality, says a Gamma Biosciences executive.